Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst

Group 1: Chemours Company (CC) - Analyst Peter Osterland initiated coverage with a Buy rating and a price forecast of $27, expecting strong earnings growth in 2025-2026 [1] - Margin expansion is anticipated in the Opteon refrigerant franchise, with a potential rebound in the TiO2 segment, where consensus estimates are seen as overly conservative [1] - Estimated EBITDA for 2024 is$775 million, for 2025 is $1.004 billion (+8$1.188 billion (+11% vs. Street) [2] Group 2: Tronox Holdings plc (TROX) - Coverage was initiated with a Buy rating and a price forecast of $17, with the company viewed as a strong player in the TiO2 industry due to its scale and vertical integration [3] - Improving TiO2 market fundamentals and potential anti-dumping duties on Chinese exports are expected to drive above-market volume growth and earnings upside [4] - Estimated EBITDA for 2024 is$563 million, for 2025 is $694 million (+6$802 million (+6% vs. Street) [4] Group 3: Minerals Technologies Inc. (MTX) - Coverage was initiated with a Buy rating and a price forecast of $103, highlighting the company's unique mineral reserves and engineering expertise as competitive advantages [5] - Sustainable mid-single-digit revenue growth is expected, with modest upside to consensus estimates for 2025-2026 [6] - Estimated EBITDA for 2024 is$404 million, for 2025 is $440 million (+3$471 million (+4% vs. Street) [6] Group 4: Westlake Corporation (WLK) - Analyst initiated coverage with a Buy rating and a price forecast of $168, noting the company's position as a vertically integrated market leader [7] - A strong cash balance of approximately$3 billion provides flexibility for further expansion through M&A or increased shareholder returns [7] - Estimated EBITDA for 2024 is $2.377 billion, for 2025 is$2.677 billion (+5% vs. Street), and for 2026 is $2.996 billion (+5% vs. Street) [8]